Catheter-associated urinary tract infections (CAUTIs) represent the most common nosocomial infection. The authors’ baseline rate of CAUTI for general medical service was elevated at 36 per 1000 catheter-days. The medical literature has consistently linked inappropriate catheter use with the development of CAUTI. The baseline data also revealed a high rate of inappropriate use of indwelling urinary catheters. Using the dual modalities of technology through prompts in the computerized order/entry system and handheld bladder scanners, as well as in combination with staff education and nurse empowerment, the authors were successful in reducing the use and duration of urinary catheters as well as the incidence of CAUTI. In subsequent data collection cycles over the following 2 years, 81% reduction in device use and a 73% reduction in the clinical end point of nosocomial CAUTI (36/1000 catheter-days to 11/1000 catheter-days; P < .001) was demonstrated.
Burke JP. Infection control: a problem for patient safety. N Engl J Med. 2003;384:651-656.
2.
Jaine P, Prada JP, David A, et al.Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med. 1995;155:1425-1429.
3.
Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med. 1991;91:65S-71S.
Weinstein JW, Mazon D, Pantelick E, et al.A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infect Control Hosp Epidemiol. 1999;20:543-548.
10.
Saint S, Wiese J, Amory JK, et al.Are physicians aware of which of their patients have indwelling catheters?Am J Med. 2000;109:476-480.
11.
Wright SW, Wreen KD, Hayes M, et al.Prevalence and risk factors for multidrug resistant uropathogens in ED patients. Am J Emerg Med. 2000;18:143-146.
12.
Tambyah PA, Maki DG. Relationship between pyuria and infection in patients with indwelling urinary catheters. Arch Intern Med. 2000;160:673-677.
13.
US Department of Health and Human Services. Guidelines for Prevention of Catheter-Associated Urinary Tract Infections. Atlanta, Ga: Centers for Disease Control and Prevention; 1981.
14.
Centers for Disease Control and Prevention. Campaign to prevent antimicrobial resistance in healthcare settings. Available at: http://www.cdc.gov/drugresistance/healthcare/ha/12steps_HA.htm.
15.
US Department of Health and Human Services. National Nosocomial Infection Surveillance System Manual. Atlanta, Ga: Centers for Disease Control and Prevention; 1999.
16.
Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheter-associated urinary tract infections in the era of managed care. Infect Control Hosp Epidemiol. 2002;23:27-31.
17.
Saint S, Elmore JG, Sullivan DS, et al.The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med. 1998;105:236-241.
